Thomas M Cascino1, Keith D Aaronson1, Garrick C Stewart2. 1. Frankel Cardiovascular Center, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA. 2. Center for Advanced Heart Disease, Division of Cardiovascular Medicine, Brigham and Women's Hospital, 75 Francis St., Boston, MA, 02115, USA. gcstewart@bwh.harvard.edu.
Abstract
PURPOSE OF REVIEW: Improving outcomes with durable mechanical circulatory support have led to expanding interest in the earlier recognition of patients destined to develop refractory heart failure (HF). The recognition of advanced HF has received increasing attention. RECENT FINDINGS: The Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) registry developed patient profiles of advanced HF to describe the spectrum of patients with refractory HF undergoing mechanical circulatory support. These patient profiles have been extended to advanced HF patients on medical therapy and used to align outcomes with medical and device therapy in the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) registries and the ROADMAP study. Shared decision-making about treatment options for advanced HF requires individualized consideration of risks and benefits beyond survival. Future studies, including the ongoing Registry for Vital Information for VADs in Ambulatory Life (REVIVAL) study, will provide prognostic information for patients transitioning from stage C to stage D HF to help patients, caregivers, and physicians navigate the increasingly complex terrain of HF care.
PURPOSE OF REVIEW: Improving outcomes with durable mechanical circulatory support have led to expanding interest in the earlier recognition of patients destined to develop refractory heart failure (HF). The recognition of advanced HF has received increasing attention. RECENT FINDINGS: The Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) registry developed patient profiles of advanced HF to describe the spectrum of patients with refractory HF undergoing mechanical circulatory support. These patient profiles have been extended to advanced HF patients on medical therapy and used to align outcomes with medical and device therapy in the Medical Arm of Mechanically Assisted Circulatory Support (MedaMACS) registries and the ROADMAP study. Shared decision-making about treatment options for advanced HF requires individualized consideration of risks and benefits beyond survival. Future studies, including the ongoing Registry for Vital Information for VADs in Ambulatory Life (REVIVAL) study, will provide prognostic information for patients transitioning from stage C to stage D HF to help patients, caregivers, and physicians navigate the increasingly complex terrain of HF care.
Authors: E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245
Authors: Vanessa Xanthakis; Danielle M Enserro; Martin G Larson; Kai C Wollert; James L Januzzi; Daniel Levy; Jayashri Aragam; Emelia J Benjamin; Susan Cheng; Thomas J Wang; Gary F Mitchell; Ramachandran S Vasan Journal: JACC Heart Fail Date: 2016-07-06 Impact factor: 12.035
Authors: Jerry D Estep; Randall C Starling; Douglas A Horstmanshof; Carmelo A Milano; Craig H Selzman; Keyur B Shah; Matthias Loebe; Nader Moazami; James W Long; Josef Stehlik; Vigneshwar Kasirajan; Donald C Haas; John B O'Connell; Andrew J Boyle; David J Farrar; Joseph G Rogers Journal: J Am Coll Cardiol Date: 2015-10-20 Impact factor: 24.094
Authors: Ayman Samman-Tahhan; Jeffrey S Hedley; Andrew A McCue; Jonathan B Bjork; Vasiliki V Georgiopoulou; Alanna A Morris; Javed Butler; Andreas P Kalogeropoulos Journal: JACC Heart Fail Date: 2018-08-08 Impact factor: 12.035
Authors: James C Fang; Gregory A Ewald; Larry A Allen; Javed Butler; Cheryl A Westlake Canary; Monica Colvin-Adams; Michael G Dickinson; Phillip Levy; Wendy Gattis Stough; Nancy K Sweitzer; John R Teerlink; David J Whellan; Nancy M Albert; Rajan Krishnamani; Michael W Rich; Mary N Walsh; Mark R Bonnell; Peter E Carson; Michael C Chan; Daniel L Dries; Adrian F Hernandez; Ray E Hershberger; Stuart D Katz; Stephanie Moore; Jo E Rodgers; Joseph G Rogers; Amanda R Vest; Michael M Givertz Journal: J Card Fail Date: 2015-05-04 Impact factor: 5.712
Authors: Randall C Starling; Jerry D Estep; Douglas A Horstmanshof; Carmelo A Milano; Josef Stehlik; Keyur B Shah; Brian A Bruckner; Sangjin Lee; James W Long; Craig H Selzman; Vigneshwar Kasirajan; Donald C Haas; Andrew J Boyle; Joyce Chuang; David J Farrar; Joseph G Rogers Journal: JACC Heart Fail Date: 2017-04-05 Impact factor: 12.035
Authors: Lynne Warner Stevenson; Leslie W Miller; Patrice Desvigne-Nickens; Deborah D Ascheim; Michael K Parides; Dale G Renlund; Ronald M Oren; Steven K Krueger; Maria Rosa Costanzo; L Samuel Wann; Ronald G Levitan; Donna Mancini Journal: Circulation Date: 2004-08-16 Impact factor: 29.690
Authors: Anneleen Baert; Delphine De Smedt; Johan De Sutter; Dirk De Bacquer; Paolo Emilio Puddu; Els Clays; Sofie Pardaens Journal: Eur J Prev Cardiol Date: 2018-01-31 Impact factor: 7.804
Authors: Merryn Gott; Sarah Barnes; Chris Parker; Sheila Payne; David Seamark; Salah Gariballa; Neil Small Journal: Palliat Med Date: 2007-03 Impact factor: 4.762
Authors: Florin Alexandru Pleșoianu; Carmen Elena Pleșoianu; Iris Bararu Bojan; Andrei Bojan; Andrei Țăruș; Grigore Tinică Journal: Bioengineering (Basel) Date: 2022-05-06